Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 181, doi. 10.1038/gt.2014.108
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2015 AND VI 22 AND IP 2
Results: 14
1
2
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 127, doi. 10.1038/gt.2014.112
- By:
- Publication type:
- Article
3
The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 209, doi. 10.1038/gt.2014.104
- By:
- Publication type:
- Article
4
Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 155, doi. 10.1038/gt.2014.98
- By:
- Publication type:
- Article
5
High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 202, doi. 10.1038/gt.2014.96
- By:
- Publication type:
- Article
6
AAV-mediated and pharmacological induction of Hsp70 expression stimulates survival of retinal ganglion cells following axonal injury.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 138, doi. 10.1038/gt.2014.105
- By:
- Publication type:
- Article
7
Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 163, doi. 10.1038/gt.2014.94
- By:
- Publication type:
- Article
8
Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 116, doi. 10.1038/gt.2014.115
- By:
- Publication type:
- Article
9
Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 146, doi. 10.1038/gt.2014.100
- By:
- Publication type:
- Article
10
Adeno-associated virus inverted terminal repeats stimulate gene editing.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 190, doi. 10.1038/gt.2014.109
- By:
- Publication type:
- Article
11
AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 196, doi. 10.1038/gt.2014.103
- By:
- Publication type:
- Article
12
Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 111, doi. 10.1038/gt.2014.106
- By:
- Publication type:
- Article
13
Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 216, doi. 10.1038/gt.2014.127
- By:
- Publication type:
- Article
14
Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.
- Published in:
- Gene Therapy, 2015, v. 22, n. 2, p. 172, doi. 10.1038/gt.2014.99
- By:
- Publication type:
- Article